Ullrich-Turner Syndrome and Neurofibromatosis-1

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 66, Issue 4, 1996, Pages 423-425

  Schorry, Elizabeth K ^a   Lovell, Anne M ^a   Milatovich, Athena ^b   Saal, Howard M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth hormone; Mixed gonadal mosaicism; Neurofibromatosis 1; Noonan syndrome; Ullrich Turner syndrome

Indexed keywords

SIMIAE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; HYPERTELORISM; KARYOTYPE; NEUROFIBROMATOSIS; NOONAN SYNDROME; PRIORITY JOURNAL; SHORT STATURE; TURNER SYNDROME; WEBBED NECK;

BRAIN NEOPLASMS; CHILD; DWARFISM; FEMALE; HUMANS; INFANT, NEWBORN; MOSAICISM; NEUROFIBROMATOSIS 1; NOONAN SYNDROME; TURNER SYNDROME;

EID: 0030459170     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8628(19961230)66:4<423::aid-ajmg6>3.0.co;2-l     Document Type: Article

References (14)

1. Abuelo DN, Meryash DL (1988): Neurofibromatosis with fully expressed Noonan syndrome. Am J Med Genet 29:937-941.
2. Allanson JE, Hall JG, Van Allen MI (1985): Noonan phenotype associated with neurofibromatosis. Am J Med Genet 21:457-462.
3. Crowe FW, Schull J, Neel JV (1956): "A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis." Springfield, IL: Charles C. Thomas.
4. Kayes LM, Burke W, Riccardi VM, Bennett R, Ehrlich P, Rubenstein A, Stephens K (1994): Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients. Am J Hum Genet 54:424-436.
5. Leppig KA, Viskochil D, Kaplan P, Stephens KG (1994): Is NP-1 gene deletion the molecular mechanism of neurofibromatosis type 1 with distinctive facies? Am J Hum Genet 55:A229.
6. Mendez HM (1985): The neurofibromatosis-Noonan syndrome. Am J Med Genet 21:471-476.
7. Mendez HM, Opitz JM (1985): Noonan syndrome: A review. Am J Med Genet 21:493-506.
8. Opitz JM, Weaver DD (1985): Editorial comment: The neurofibromatosis-Noonan syndrome. Am J Med Genet 21:477-490.
9. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, Frane J, Gotlin RW, Kuntze J, Lippe B, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V (1988): Three-year results of a randomized prospective trial of methionyl human growth hormone and oxalandrolone in Turner syndrome. J Pediatr 113:393-400.
10. Shuper A, Mukamel M, Mimouni M, Steinherz R (1987): Noonan's syndrome and neurofibromatosis. Arch Dis Child 62:196-198.
11. Stern HJ, Saal HM, Lee JS, Fain PR, Golgar DE, Rosenbaum KN, Barker DF (1992): Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome? J Med Genet 29: 184-187.
12. Thompson MW, McInnes RR, Willard HF (1991): "Genetics in Medicine." 5th Ed. Philadelphia: W.B. Saunders Co., p 241.
13. Upadhyaya M, Fryer A, MacMillan J, Broadhead W, Huson SM, Harper PS (1992): Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1. J Med Genet 29:180-183.
14. Wu BL, AustinMA,SchneiderGH, BolesRG, KorfBR(1995): Deletion of entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations. Am J Hum Genet 57:A34.